Personalized chemo dosing study for colon cancer withdrawn before start
NCT ID NCT06501989
First seen Feb 13, 2026 · Last updated May 01, 2026 · Updated 17 times
Summary
This study aimed to see if adjusting the dose of the chemotherapy drug 5-FU based on its level in the blood could improve treatment for people with metastatic colorectal cancer. It planned to enroll adults with this cancer who had not received prior treatment for metastatic disease. However, the study was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Inova Health Care Service
Falls Church, Virginia, 22042, United States
Conditions
Explore the condition pages connected to this study.